EU Wants Legislative Review To Support ‘World Class’ Pharmaceutical Industry
The European health commissioner has told members of parliament that a balance needs to be struck between promoting innovation and maximizing access to medicines across the EU member states.
You may also be interested in...
Health care and medicines are among the priorities outlined by the new presidency of the Council of the EU for the first half of 2023.
A group of EU member states has written to the European Commission saying that an exclusivity voucher scheme intended to stimulate R&D into new antimicrobials will stifle innovation by competitor companies and push up costs for national health systems.
European Commission plans for an overhaul of the pharmaceutical legislation would halve market protection for orphan drugs and risk the predictability of the regulatory system, warns industry expert.